Conference abstract · 6 Dec 2019
Conference abstractPublished 26 Sep 2016
Inflammatory bowel disease: Therapy
BenemÃ?©rita Universidad AutÃ?³noma de Puebla, Mexico
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Many therapies are available for patients with inflammatory bowel disease (IBD). Medical therapies include aminosalicylates drugs such as sulfasalazine, olsalazine, balsalazide, and various formulations of mesalamine; antibiotics; corticosteroids; immune-suppressive medications as azathioprine, 6-mercaptopurine (6-MP), methotrexate, and cyclosporine; and biotechnology medications such as anti-tumor necrosis factor (TNF) agents and newer agents with different mechanisms of action. Many surgical therapies also are used in patients with IBD. Some of the treatments are designed to deliver medication to specific areas of the bowel, while others act systemically. A thorough understanding of the anatomical distribution of inflammation is required in order to choose the optimal drug for a given patient. Ulcerative colitis can be divided into ulcerative proctitis, ulcerative proctosigmoiditis, left- sided ulcerative colitis, and extensive colitis or pancolitis. CrohnâÂ?Â?s disease can be divided into ileitis, colitis, and ileocolitis. Amino-salicylates, sulfasalazine, oral mesalamine, rectal mesalamine, olsalazine and balsalazide are drugs that deliver 5-ASA to the bowel lumen. In sulfasalazine, 5- ASA is linked to sulfa-pyridine by an azo-bond, which keeps the 5- ASA inactivated until the azo bond, is cleaved by bacterial enzymes. Olsalazine and balzalacide are prodrugs with 5-ASA bound by an azo bond. 5-ASA is available covered either a pH dependent polymer that dissolves in the terminal ileum and cecum, as ethyl cellulose coated granules that release drug throughout the gastro-intestinal tract; or in more complex delivery systems that result in prolomged mesalamine release throughout the colon. Mesalamine can also be administered to treat left-sided colitis or proctosimoiditis or as a suppository to treat proctitis. Antibiotics controlled trials of various antibiotics have not demonstrated efficacy in treating ulcerative colitis. The data to use antibiotics in CrohnâÂ?Â?s disease are less clear cut. Three small studies suggested efficacy of metronidazole and ciprofloxacin. Controlled trials of metronidazole and ornidazole after ileal resection showed that postoperative endoscopic recurrence of disease could be delayed after resection for CrohnâÂ?Â?s disease. Conclusions: Knowledge of the individual drugs and their characteristics with regard to whether the drug treats systemic disease or local disease, and where in the gastrointestinal tract it releases active drug is critical for successful treatment in patients with IBD.
Subjects
Gastroenterology & HepatologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 7 Sep 2018
Novel Therapies in Pediatric Inflammatory Bowel Disease
Conference abstract · 25 Aug 2015
Withdrawal of Anti-TNFα therapy in Inflammatory bowel disease: Is it feasible?
Mini review · 31 May 2024
Advances in Biologic Therapies for Inflammatory Bowel Disease: Efficacy and Safety Profiles
Opinion · 15 Sep 2023
Emerging therapies and treatment paradigms in inflammatory bowel disease management
More from this journal
The newest in Journal of Gastrointestinal & Digestive System.
Research article · 1 Jan 2026
Prospective Observational Study for the Evaluation of Efficacy and Safety Profile of Probiotics Food Supplement in Children with Acute Diarrhea
Case report · 11 Nov 2025
Bitter Guard: A Gut Wrenching Surprise
Research article · 18 Jun 2025
Ursodeoxycholic Acid Treatment of LPAC Presenting as Post Cholecystectomy Pain: Rationale and Design of a Randomised Trial
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Gastrointestinal & Digestive System
- SubjectGastroenterology & Hepatology
- BylineArticles whose byline prints “Ubaldo Arturo Pimentel Aguilar”
